Stem cell-based products for veterinary use: specific questions on target animal safety to be addressed by the Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)

Current version

PDF iconProblem statement

Deadline for comments: 30/09/2016

Reference numberEMA/CVMP/ADVENT/193811/2016
Published25/07/2016
Keywordsanimal stem cell -based products (ASCP), target animal safety (TAS) studies, veterinary, mesenchymal
DescriptionThis problem statement provides the basis for development of a guidance on target animal safety in relation to stem cell products intended for veterinary use. If you have any comments on the content of the document, use this . The completed comments form should be sent to vet-guidelines@ema.europa.eu.


Related content


How useful was this page?

Add your rating